NEUROONE MEDICAL TECHNOLOGIES Corp Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Return On Assets for the quarter ending September 30, 2024 was -229 %, a 48.4% decline year-over-year.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Return On Assets for 2024 was -229 %, a 48.4% decline from 2023.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Return On Assets for 2023 was -154 %, a 115% decline from 2022.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Return On Assets for 2022 was -71.9 %, a 32.1% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -229 -74.8 -48.4% Jul 1, 2024 Sep 30, 2024
Q2 2024 -200 -85.9 -75.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 -204 -113 -124% Jan 1, 2024 Mar 31, 2024
Q4 2023 -200 -126 -170% Oct 1, 2023 Dec 31, 2023
Q3 2023 -154 -82.6 -115% Jul 1, 2023 Sep 30, 2023
Q2 2023 -114 -25.2 -28.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -91 +2.48 +2.65% Jan 1, 2023 Mar 31, 2023
Q4 2022 -74.2 +18 +19.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -71.9 +34 +32.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -88.8 +2.77 +3.03% Apr 1, 2022 Jun 30, 2022
Q1 2022 -93.5 +71.9 +43.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -92.2 +145 +61.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 -106 +305 +74.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -91.5 +547 +85.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -165 +436 +72.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 -237 +315 +57.1% Oct 1, 2020 Dec 31, 2020
Q3 2020 -411 +108 +20.9% Jul 1, 2020 Sep 30, 2020
Q2 2020 -638 Apr 1, 2020 Jun 30, 2020
Q1 2020 -602 Jan 1, 2020 Mar 31, 2020
Q4 2019 -551 Oct 1, 2019 Dec 31, 2019
Q3 2019 -520 Jul 1, 2019 Sep 30, 2019
Q2 2018 -2.09K -1.02K -95.5% Apr 1, 2018 Jun 30, 2018
Q1 2018 -2.74K -2.34K -583% Jan 1, 2018 Mar 31, 2018
Q4 2017 -3.55K -3.52K -14148% Oct 1, 2017 Dec 31, 2017
Q3 2017 -1.16K +969 +45.5% Jul 1, 2017 Sep 30, 2017
Q2 2017 -1.07K -951 -791% Apr 1, 2017 Jun 30, 2017
Q1 2017 -402 -284 -242% Jan 1, 2017 Mar 31, 2017
Q4 2016 -24.9 +98.7 +79.9% Oct 1, 2016 Dec 31, 2016
Q3 2016 -2.13K -2.08K -3931% Jul 1, 2016 Sep 30, 2016
Q2 2016 -120 -23.7 -24.6% Apr 1, 2016 Jun 30, 2016
Q1 2016 -118 -33.1 -39.1% Jan 1, 2016 Mar 31, 2016
Q4 2015 -124 -53.5 -76.3% Oct 1, 2015 Dec 31, 2015
Q3 2015 -52.8 +5.04K +99% Jul 1, 2015 Sep 30, 2015
Q2 2015 -96.5 +4.81K +98% Apr 1, 2015 Jun 30, 2015
Q1 2015 -84.5 +4.15K +98% Jan 1, 2015 Mar 31, 2015
Q4 2014 -70.1 +1.54K +95.6% Oct 1, 2014 Dec 31, 2014
Q3 2014 -5.1K -3.69K -262% Jul 1, 2014 Sep 30, 2014
Q2 2014 -4.91K -3.65K -291% Apr 1, 2014 Jun 30, 2014
Q1 2014 -4.24K -3.9K -1149% Jan 1, 2014 Mar 31, 2014
Q4 2013 -1.61K -1.28K -389% Oct 1, 2013 Dec 31, 2013
Q3 2013 -1.41K -1.03K -270% Jul 1, 2013 Sep 30, 2013
Q2 2013 -1.25K -921 -276% Apr 1, 2013 Jun 30, 2013
Q1 2013 -339 -7.05 -2.12% Jan 1, 2013 Mar 31, 2013
Q4 2012 -329 Oct 1, 2012 Dec 31, 2012
Q3 2012 -380 Jul 1, 2012 Sep 30, 2012
Q2 2012 -333 Apr 1, 2012 Jun 30, 2012
Q1 2012 -332 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.